keidkeidHome
10-QFiling Date: Apr 22, 2026

Elevance Health (ELV) 10-Q (Apr 22, 2026)

elv-20260331

View SEC Filing
ACC: 0001156039-26-000043
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$50.18B
Net Income$1.76B
Total Assets$125.83B
Stockholders' Equity$44.04B
Operating Cash Flow$4.33B

More filings from Elevance Health (ELV)

  • 8-KElevance Health (ELV) 8-K · Sep 10, 2026Reg FD Disclosure
  • 10-QElevance Health (ELV) 10-Q · Jul 15, 2026Quarterly Report · ended 2026-06-30 · Rev $50.5B, NI $1.5B
  • 8-KElevance Health (ELV) 8-K · Jul 15, 2026Earnings Release; Financial Statements
  • 8-KElevance Health (ELV) 8-K · Jun 10, 2026
  • 8-KElevance Health (ELV) 8-K · May 13, 2026
  • 8-KElevance Health (ELV) 8-K · Apr 22, 2026

Recent 10-Q filings from other companies

  • 10-QLennar 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $8.0B, NI $283.9M
  • 10-QNike (NKE) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $11.2B, NI $712.0M
  • 10-QDarden Restaurants (DRI) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-30 · Rev $3.2B, NI $233.4M
  • 10-QMccormick & (MKC) 10-Q · Oct 1, 2026Quarterly Report · ended 2026-08-31 · Rev $5.8B, NI $97.6M
  • 10-QConagra Brands (CAG) 10-Q · Sep 30, 2026Quarterly Report · ended 2026-08-30 · Rev $2.6B, NI $174.3M
E

Elevance Health (ELV)

10-QELV

Quarterly Report (10-Q)

Filing Date
Apr 22, 2026
Document
elv-20260331
ACC
0001156039-26-000043
View SEC Filing

keid analysis is for reference only and does not constitute investment advice.